SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 4th, 2024 • Akari Therapeutics PLC • Pharmaceutical preparations • New York
Contract Type FiledJune 4th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 29, 2024 between Akari Therapeutics, Plc, a public company with limited liability incorporated under the laws of England and Wales (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 4th, 2024 • FibroBiologics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 4th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June [●], 2024, between FibroBiologics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 4th, 2024 • Akari Therapeutics PLC • Pharmaceutical preparations • New York
Contract Type FiledJune 4th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 29, 2024 between Akari Therapeutics, Plc, a public company with limited liability incorporated under the laws of England and Wales (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 4th, 2024 • Microbot Medical Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledJune 4th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 3, 2024, between Microbot Medical Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).